Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 721740 of 20,252 grants

Active NON-SBIR/STTR RPGS
Innovative mRNA vaccines to enhance the efficacy of T-cell transfer therapies against solid tumors
NATIONAL CANCER INSTITUTE University of California Los Angeles United States 2024 – 2029

ABSTRACT The remarkable effectiveness of the COVID-19 mRNA vaccines heralds a transformative immunization platform against viral infections. A key innovation—recognized with the 20...

$6.28M
USD
Active OTHER RESEARCH-RELATED
Developing and Testing an Interactive Visual Aid for Approaching Decision Making to Stop Cancer Treatment in Advanced Cancer
NATIONAL CANCER INSTITUTE Dartmouth-Hitchcock Clinic United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT The long-term objective of this K08 Mentored Clinical Scientist Research Career Development Award is to prepare the candidate for an independent research c...

$2.57M
USD
Active OTHER RESEARCH-RELATED
Development and Assessment of Nicotine Continuum of Risk Education on Tobacco Use Among Socioeconomically Disadvantaged Adults
NATIONAL CANCER INSTITUTE Virginia Commonwealth University United States 2024 – 2029

PROJECT SUMMARY Adults who are socioeconomically disadvantaged (“Low-SES”) are at increased risk of heavy smoking, face reduced cessation success, and bear a disproportionate burde...

$1.89M
USD
Active TRAINING, INDIVIDUAL
Defining the genetic mechanisms of ETS1 dependency in Notch-activated T Cell Acute Lymphoblastic Leukemia (T-ALL)
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2024 – 2026

PROJECT SUMMARY Over 60% of T cell acute lymphoblastic leukemias (T-ALLs) harbor mutations in the NOTCH1 signaling pathway, making Notch activation the most common oncogenic pathwa...

$494.9K
USD
Active NON-SBIR/STTR RPGS
Interrogating the Spatial and Functional Relevance of Microbes in Pancreatic Cancer and Metastasis
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2024 – 2029

Abstract/ Summary Pancreatic ductal adenocarcinoma (PDAC) represents one of the most aggressive malignancies, with more than 50% of patients with pancreatic cancer presenting with...

$5.38M
USD
Active NON-SBIR/STTR RPGS
Chemical biological analysis of RAF Kinases
NATIONAL CANCER INSTITUTE University of Washington United States 2024 – 2029

Abstract The serine/threonine Raf Kinases function as downstream modulators of RAS GTPase-driven signaling and are key drivers of many oncogenic signaling networks. Despite extensi...

$5.09M
USD
Active TRAINING, INDIVIDUAL
Tissue-Resident Adaptive CD56bright NK Cell Responses in Cancer
NATIONAL CANCER INSTITUTE University of Minnesota United States 2024 – 2028

ABSTRACT Natural killer (NK) cells are key mediators of anti-tumor immune responses, acting to directly kill cancer cells (CD56dim subtype) and recruit pro-inflammatory immune popu...

$535.3K
USD
Active TRAINING, INDIVIDUAL
Defining the role of stress granules in cancer initiation
NATIONAL CANCER INSTITUTE Boston Children'S Hospital United States 2024 – 2027

Project Summary. Stress granules (SGs) – cytoplasmic aggregates formed from stalled translation initiation complexes upon cell stress – have emerged as critical regulators of oncog...

$738.3K
USD
Active NON-SBIR/STTR RPGS
SCH: Topological Methods for Breast Tissue Quantification
NATIONAL CANCER INSTITUTE State University New York Stony Brook United States 2024 – 2028

To better understand breast cancer and its response to treatment, the key is to understand breast tissue architecture. Modifications to tissue architecture are a direct consequence...

$3M
USD
Active NON-SBIR/STTR RPGS
SCH: Synchronous Dyadic Physiological Monitoring for Real Time In Vivo Measurement and
NATIONAL CANCER INSTITUTE North Carolina State University Raleigh United States 2024 – 2028

Animal-Assisted Interventions (AAIs) are goal-oriented programs that intentionally incorporate animals, such as dogs, for therapeutic benefits. AAIs are widely used in a variety of...

$3M
USD
Active NON-SBIR/STTR RPGS
SCH: Robust Multimodal Longitudinal AI for Enhanced Breast Cancer Screening
NATIONAL CANCER INSTITUTE University of Connecticut Storrs United States 2024 – 2028

The overarching objective of this project is to optimize and personalize breast cancer screening by advancing artificial intelligence (AI) algorithms. Breast cancer is a major glob...

$3.1M
USD
Completed OTHER RESEARCH-RELATED
Administrative supplement to expand cancer clinical trial capacity in sub-Saharan Africa
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2024 – 2025

SUMMARY This application is being submitted in response to Notice of Special Interest (NOSI) NOT-CA-24-039. Given the rising incidence and poor outcomes associated with cancer in N...

$864K
USD
Active OTHER RESEARCH-RELATED
Native American Youths Enjoy Science - YES Oklahoma
NATIONAL CANCER INSTITUTE University of Oklahoma Hlth Sciences Ctr United States 2024 – 2027

PROJECT SUMMARY The “YES Oklahoma” program provides a pathway that sustains an enhanced representation of Oklahoma American Indian students in cancer research. Our program is suppo...

$3.99M
USD
Completed OTHER RESEARCH-RELATED
7th Annual Workshop on Confocal Microscopy for Cutaneous Diagnostics
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2024 – 2025

Project Summary Skin cancers are the most common cancers in the U.S and often require biopsy for histopathology confirmation. However, ~70% of biopsies yield benign findings, repre...

$80K
USD
Active NON-SBIR/STTR RPGS
Polyploidy and Sex Dimorphism in a Drosophila Tumor Model
NATIONAL CANCER INSTITUTE Tulane University of Louisiana United States 2024 – 2029

Project Summary Ploidy variation is a cancer hallmark and is frequently associated with poor prognosis in high-grade cancers. Such variation can include an increase in chromosome s...

$3.41M
USD
Completed OTHER RESEARCH-RELATED
21st International Conference of the Society for Integrative Oncology
NATIONAL CANCER INSTITUTE Beckman Research Institute/City of Hope United States 2024 – 2025

PROJECT SUMMARY/ABSTRACT The Society for Integrative Oncology (SIO) 21st International Conference, "Full Circle Translational Integrative Oncology: Bedside to Bench and Back -...

$100K
USD
Active NON-SBIR/STTR RPGS
Targeting CD180 to induce anti-KSHV response in nonhuman primates
NATIONAL CANCER INSTITUTE Oregon Health & Science University United States 2024 – 2029

SUMMARY The overall goals of this U01 application are two-fold. First, to investigate two potential KSHV targets, one structural and one non-structural, to determine if these two t...

$12.13M
USD
Active NON-SBIR/STTR RPGS
Defining Critical Sites of Vulnerability and Correlates of Protection to Kaposi Sarcoma Associated Herpesvirus to Inform Vaccine Design
NATIONAL CANCER INSTITUTE Fred Hutchinson Cancer Center United States 2024 – 2029

PROJECT SUMMARY Kaposi sarcoma-associated herpesvirus (KSHV) is an oncogenic virus that causes Kaposi sarcoma (KS), one of the most common malignancies in people living with HIV wo...

$7.68M
USD
Active SBIR-STTR RPGS
Development of a Molecular Assay to Diagnose Malignant Pleural Effusions
NATIONAL CANCER INSTITUTE Precision Epigenomics, Inc United States 2024 – 2026

Precision Epigenomics Inc, is a University of Arizona Cancer Center and Department of Pathology, spin out, aiming to launch molecular diagnostic tests for cancer patients. The prod...

$10.04M
USD
Completed RESEARCH CENTERS
Cancer Center Administration
NATIONAL CANCER INSTITUTE University of Utah United States 2024 – 2025

ADMINISTRATION ABSTRACT Huntsman Cancer Institute (HCI) Administration supports the Cancer Center’s mission to provide excellence in innovative basic, translational, population sci...